Skip to main content
. 2021 Feb 18;12:623684. doi: 10.3389/fpsyt.2021.623684

Table 1.

Receptor binding profiles of antipsychotic agents.

Receptor LUR APZ CLZ PMZ QTP RIS ZTP BNS VTX
5-HT1AR 6.8 5.6 124 650 432 423 471 804 15.0
5-HT2AR 2.0 8.7 5.4 48.4 100 0.2 2.7 0.8
5-HT3R >1,000 630 241 >1,000 >1,000 >1,000 472 >1,000 3.7
5-HT7R 0.5 10.3 18.0 0.5 307 6.6 12.0 183 19.0
α2A >1,000 74.3 37.0 >1,000 >1,000 16.5 180 (530)
α2B >1,000 102 26.5 821 90.0 108 5.4
α2C 10.8 37.9 6.0 377 28.7 1.3 106
D1R 262 >1,000 266 >1,000 712 244 71.0 >1,000
D2R 1.7 3.3 157 0.3 245 3.6 25.0 0.1
References (26) (27, 28) (29, 30) (31) (32) (28, 33) (34) (35) (36)

lurasidone (LUR), aripiprazole (APZ), clozapine (CLZ), pimozide (PMZ), risperidone (RIS), zotepine (ZTP), and blonanserin (BNS), and antidepressant vortioxetine (VTX) against serotonin (5-HT) type 1A (5-HT1AR), type 2A (5-HT2AR), type 3 (5-HT3R), and type 7 (5-HT7R) receptor, and dopamine receptors type 1 (D1R) and 2 (D2R). Data are equilibrium constant (Ki) values (nM).